Product Description

Halofuginone is a coccidiostat used in veterinary medicine. This synthetic enzyme inhibitor is derived from febrifugine, a quinazoline alkaloid isolated in Dichroa febrifuga. As a halogenated quinazoline derivative, Halofuginone contains a fused pair of aromatic rings, benzene and pyrimidine.

The chemical selectively regulates the autoimmune disease-promotive T helper 17 cell development. Halofuginone also controls cell migration, collagen type I synthesis and MMP-2 gene expression to inhibit proliferative tumor activity. In mice, Halofuginone has suppressed tumors and cancerous metastasis by functioning as a high-affinity inhibitor to glutamyl-prolyl tRNA synthetase. This inhibition induces anti-inflammatory and anti-fibrotic effects by means of the amino acid starvation response.

Medicinally, Halofuginone qualifies as an anti-inflammatory, antiprotozoal and anti-angiogenic agent. When fed to animals, it prevents coccidiosis. In studies of osteoarthritis, Halofuginone inhibited TGF-β activity and H-type vessel formation, attenuating the condition.

Product Specifications

Formula: C16H17BrClN3O3

MW: 414.68 g/mol

Storage/Handling: Store at room temperature.

PubChem Chemical ID: 62891

Product Specifications

Catalog ID B-250
CAS # 55837-20-2
MW 414.68 g/mol
Storage/Handling Store at room temperature.

Technical Documentation

P Protocol
O Other
C Certificate of Analysis
S Safety Data Sheet

View Sizes & Pricing

Catalog Number:
{{ currentSelection && currentSelection.sku ? currentSelection.sku : '...' }}
CAS Number:
{{ casNumber && casNumber.value ? casNumber.value : '...' }}
On Sale:
${{ currentSelection.price }} ${{ currentSelection.sale_price }}
$9.99 Ground shipping (In continental US only.)

Join our list to receive promos and articles.

Join Now